Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 4, 2015, Pages 791-798.e1

  Dalton Fitzgerald, Eimile ^a,d   Tiro, Jasmin ^b,c   Kandunoori, Pragathi ^a,d   Halm, Ethan A ^a,c,d   Yopp, Adam ^a,b   Singal, Amit G ^a,b,c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

AFP; Early Detection; Liver Cancer; Screening

Indexed keywords

ALPHA FETOPROTEIN; LIVER ENZYME;

ADULT; ARTICLE; CANCER MORTALITY; CLINICAL EXAMINATION; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTERPERSONAL COMMUNICATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MEDICAL PRACTICE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; SELF REPORT; ULTRASOUND; CARCINOMA, HEPATOCELLULAR; CLINICAL PRACTICE; COMPLICATION; EARLY DIAGNOSIS; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HEALTH SERVICES RESEARCH; LIVER NEOPLASMS; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; QUESTIONNAIRE; UNITED STATES;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; SURVEYS AND QUESTIONNAIRES; TEXAS;

EID: 84924987925     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.06.031     Document Type: Article

References (40)

1. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
2. Singal A.G., Marrero J.A. Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 2010, 26:189-195.
3. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999, 29:62-67.
4. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEngl J Med 1996, 334:693-699.
5. Zhang B.H., Yang B.H., Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. JCancer Res Clin Oncol 2004, 130:417-422.
6. Singal A.G., Pillai A., Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014, 11:e1001624.
7. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010, 53:1-35.
8. Singal A., Volk M.L., Waljee A., et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009, 30:37-47.
9. Davila J.A., Henderson L., Kramer J.R., et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 2011, 154:85-93.
10. Singal A.G., Conjeevaram H.S., Volk M.L., et al. Effectiveness ofhepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev 2012, 21:793-799.
11. Singal A.G., Marrero J.A., Yopp A. Screening process failures for hepatocellular carcinoma. JNatl Compr Canc Netw 2014, 12:375-382.
12. Singal A.G., Yopp A., Skinner S.C., et al. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. JGen Intern Med 2012, 27:861-867.
13. Singal A.G., Li X., Tiro J.A., Kandunoori P., et al. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med 2014 Aug 9, Epub ahead of print.
14. Singal A.G., Yopp A.C., Gupta S., et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) 2012, 5:1124-1130.
15. Sanyal A., Poklepovic A., Moyneur E., et al. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 2010, 26:2183-2191.
16. Bandura A. Health promotion by social cognitive means. Health Educ Behav 2004, 31:143-164.
17. Michels T.C., Taplin S.M., Carter W.B., et al. Barriers to screening: the theory of reasoned action applied to mammography use in a military beneficiary population. Mil Med 1995, 160:431-437.
18. Yabroff K.R., Klabunde C.N., Yuan G., et al. Are physicians' recommendations for colorectal cancer screening guideline-consistent?. JGen Intern Med 2011, 26:177-184.
19. Klabunde C.N., Jones E., Brown M.L., et al. Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologists. AJR Am J Roentgenol 2002, 179:1419-1427.
20. Klabunde C.N., Frame P.S., Meadow A., et al. Anational survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med 2003, 36:352-362.
21. Klabunde C.N., Vernon S.W., Nadel M.R., et al. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 2005, 43:939-944.
22. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. Anational survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005, 142:86-94.
23. Beatty P., Willis G. Research synthesis: the practice of cognitive interviewing. Publ Opin Q 2007, 71:287-311.
24. Willis G. Cognitive interviewing: a tool for improving questionnaire design 2004, Sage Publications, Thousands Oaks, CA.
25. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
26. Chalasani N., Said A., Ness R., et al. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol 1999, 94:2224-2229.
27. Khalili M., Guy J., Yu A., et al. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci 2011, 56:1516-1523.
28. Saab S., Nguyen S., Ibrahim A., et al. Management of patients with cirrhosis in Southern California: results of a practitioner survey. JClin Gastroenterol 2006, 40:156-161.
29. Davila J.A., Morgan R.O., Richardson P.A., et al. Use of surveillance for hepatocellular carcinoma among patients withcirrhosis in the United States. Hepatology 2010, 52:132-141.
30. Singal A.G., Nehra M., Adams-Huet B., et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?. Am J Gastroenterol 2013, 108:425-432.
31. Trevisani F., De N.S., Rapaccini G., et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002, 97:734-744.
32. Gupta S., Bent S., Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003, 139:46-50.
33. Pocha C., Dieperink E., McMaken K.A., et al. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study. Aliment Pharmacol Ther 2013, 38:303-312.
34. Orlandi M.A. Promoting health and preventing disease in health care settings: an analysis of barriers. Prev Med 1987, 16:119-130.
35. Pommerenke F.A., Dietrich A. Improving and maintaining preventive services. Part 1: applying the patient path model. JFam Pract 1992, 34:86-91.
36. Singal A.G., Tiro J.A., Gupta S. Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol 2013, 11:472-477.
37. Levin T.R., Jamieson L., Burley D.A., et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011, 33:101-110.
38. Singal A., Volk M., Rakoski M., et al. Patient Involvement is correlated with higher HCC surveillance in patients with cirrhosis. JClin Gastroenterol 2011, 45:727-732.
39. Singal A.G., Chan V., Getachew Y., et al. Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital. Dig Dis Sci 2012, 57:580-586.
40. Yopp A.C., Mansour J.C., Beg M.S., et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol 2014, 21:1287-1295.